Miura M, Matsukado Y, Kodama T, Mihara Y
J Neurosurg. 1985 Mar;62(3):376-82. doi: 10.3171/jns.1985.62.3.0376.
The clinical and histopathological characteristics in six cases of gonadotropin-producing adenoma are presented. Definitive diagnosis was made by the determination of gonadotropin levels in culture medium. Several authors have reported that gonadotropin-producing adenomas are very rare; however, hormonal assay of adenoma cell culture medium may indicate the real incidence of gonadotropin-producing adenomas to be greater than is thought. In reported cases, practically no endocrinological symptoms have been found suggesting increased gonadotropin levels, and basal values of plasma gonadotropins have been reported as only slightly over the normal range. Gonadotropin-producing adenomas may have been misdiagnosed as nonsecreting adenomas. The clinical characteristics of gonadotropin-producing adenomas can be summarized as follows: 1) a tendency for more rapid growth than nonsecreting adenomas; 2) prominent suprasellar extension with marked enhancement on computerized tomography; and 3) diminished response of luteinizing hormone (LH) alone in response to LH-releasing hormone (LH-RH) stimulation, and the ratio of peak follicle-stimulating hormone to peak LH in the LH-RH stimulation test is more frequently over 1:1 in cases of gonadotropin-producing adenoma than in cases of nonsecreting adenoma and craniopharyngioma. Immunoperoxidase staining revealed two kinds of adenoma cells, one intensely and the other faintly stained. Abundant mitochondria and few secretory granules were characteristic electron microscopic features. Oncocytic transformation of adenoma cells was suggested by immunoperoxidase staining and the electron microscopic appearance, and may suppress the elevation of circulating plasma gonadotropin levels. Thus, hormonal assay of adenoma cell culture medium and immunoperoxidase staining are essential for definitive diagnosis of gonadotropin-producing adenomas.
本文介绍了6例促性腺激素分泌性腺瘤的临床和组织病理学特征。通过测定培养基中的促性腺激素水平做出明确诊断。几位作者报告促性腺激素分泌性腺瘤非常罕见;然而,对腺瘤细胞培养基进行激素检测可能表明促性腺激素分泌性腺瘤的实际发病率高于人们的想象。在已报道的病例中,几乎未发现提示促性腺激素水平升高的内分泌症状,并且血浆促性腺激素的基础值仅略高于正常范围。促性腺激素分泌性腺瘤可能被误诊为无分泌性腺瘤。促性腺激素分泌性腺瘤的临床特征可总结如下:1)比无分泌性腺瘤生长更快的倾向;2)蝶鞍上扩展明显,计算机断层扫描显示明显强化;3)单独的黄体生成素(LH)对促黄体生成素释放激素(LH-RH)刺激的反应减弱,并且在LH-RH刺激试验中,促性腺激素分泌性腺瘤病例中促卵泡生成素峰值与LH峰值的比值比无分泌性腺瘤和颅咽管瘤病例更频繁地超过1:1。免疫过氧化物酶染色显示两种腺瘤细胞,一种染色深,另一种染色浅。丰富的线粒体和少量分泌颗粒是特征性的电子显微镜特征。免疫过氧化物酶染色和电子显微镜表现提示腺瘤细胞发生嗜酸性变,这可能抑制循环血浆促性腺激素水平的升高。因此,对腺瘤细胞培养基进行激素检测和免疫过氧化物酶染色对于促性腺激素分泌性腺瘤的明确诊断至关重要。